NCT06490393 The Impact of Supervision by a Health Care Professional on Quality of Life Questionnaire
| NCT ID | NCT06490393 |
| Status | Recruiting |
| Phase | — |
| Sponsor | St. Claraspital AG |
| Condition | Health-related Quality of Life |
| Study Type | OBSERVATIONAL |
| Enrollment | 200 participants |
| Start Date | 2024-04-17 |
| Primary Completion | 2026-05-01 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 200 participants in total. It began in 2024-04-17 with a primary completion date of 2026-05-01.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
Effect of supervision on scoring and completion on Quality of Life Questionnaire
Eligibility Criteria
Inclusion Criteria: * Patient is ≥18 years of age and legally competent * Signed informed consent available * Systemic oncologic treatment (e.g. chemotherapy, immunotherapy, endocrine therapy) * Current systemic therapy started at least 4 weeks before randomization and is scheduled to continue for at least another 4 weeks after randomization in the same dose and interval * Patient is ready and able to complete quality of life questionnaires in German (on paper Exclusion Criteria: * One or more of the inclusion criteria not met.
Contact & Investigator
Diana de Jong-Bakker
PRINCIPAL INVESTIGATOR
St. Claraspital Klinische Forschung
Frequently Asked Questions
Who can join the NCT06490393 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying Health-related Quality of Life. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06490393 currently recruiting?
Yes, NCT06490393 is actively recruiting participants. Contact the research team at diana.bakkerdejong@claraspital.ch for enrollment information.
Where is the NCT06490393 trial being conducted?
This trial is being conducted at Basel, Switzerland.
Who is sponsoring the NCT06490393 clinical trial?
NCT06490393 is sponsored by St. Claraspital AG. The principal investigator is Diana de Jong-Bakker at St. Claraspital Klinische Forschung. The trial plans to enroll 200 participants.